Moshkovich, Olga http://orcid.org/0000-0001-6464-8533
Benjamin, Katy
Hall, Katie
Murphy, Ryan
von Maltzahn, Robyn
Gorsh, Boris
Sikirica, Vanja
Saini, Rajnish
Sprecher, Dennis
Funding for this research was provided by:
GlaxoSmithKline
Article History
Accepted: 16 May 2020
First Online: 28 May 2020
Change Date: 17 September 2020
Change Type: Correction
Change Details: The article Development of a conceptual model and patient-reported outcome measures for assessing symptoms and functioning in patients with heart failure.
Compliance with ethical standards
:
: KH, RM, and OM have no conflicts of interest to report. RvM and RS are employees and stock holders of GSK. KB is an employee of AbbVie. VS is a stockholder of Novartis. BG, VS, and DS were GSK employees at the time of the study. KH and KB were employees of ICON at the time of the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The ethics bodies that approved the study at the three clinical sites were as follows: Site names: MedStar Health Research Institute, University of Colorado Health Memorial Health System, Health Institutional Review Board, and The Valley Hospital. IRB used: Western Institutional Review Board, University of Colorado Health Institutional Review Board, and Western Institutional Review. IRB protocol numbers: 20151655, #15-6036, and 20151655.
: Informed consent was obtained from all individual participants included in the study.